Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Hereditary Hemorrhagic Telangiectasia Impact Genetics Dynacare/LabCorp Canada | 5 | 3 |
|
Comprehensive Aortopathy Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 54 | 48 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 7 | 12 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 23 | 30 |
|
Marfan and Related Conditions Panel Mayo Clinic Laboratories Mayo Clinic United States | 37 | 30 |
|
Health in Code Spain | 71 | 35 |
|
Aortic Valvular Diseases Panel Health in Code Spain | 60 | 30 |
|
Department of Clinical Genetics Odense University Hospital Denmark | 1 | 1 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics United States | 94 | 55 |
|
Centogene US, LLC - The Rare Disease Company United States | 4 | 1 |
|
Centogene US, LLC - The Rare Disease Company United States | 67 | 33 |
|
Centogene US, LLC - The Rare Disease Company United States | 114 | 68 |
|
Centogene US, LLC - The Rare Disease Company United States | 156 | 107 |
|
Centogene US, LLC - The Rare Disease Company United States | 218 | 135 |
|
SMAD4 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 4 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 67 | 33 |
|
Centogene AG - the Rare Disease Company Germany | 114 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.